Trading Signals: CGEN Stock Price Prediction and Forecast (Wed. Jun. 11, 2003 - Fri. May. 13, 2022)(Compugen Ltd.)
| CGEN latest price $8.0100 (-3.14%) ($8.0100 - $8.0100) on Thu. Jul. 1, 2021. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 4.11% (three month average) | RSI | 52 | Latest Price | $8.0100(-3.14%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | CGEN declines -1.1% a day on average for past five trading days. | Weekly Trend | CGEN advances 2.7% a week on average for past two weeks. | Market Behavior | Broad based rally for large cap. Broad based rally for small cap. | Correlated ETFs | Broad market will support CGEN advance at 0% a week (0% probability) XBI(71%) ARKG(69%) ARKK(66%) IWO(65%) ACES(62%) | Factors Impacting CGEN price | CGEN will decline at least -2.055% in a week (0% probabilities). VIXM(-48%) VXX(-37%) UUP(-16%) TLT(-8%) IGOV(-4%) | | | | | Relative Volatility | | | | Market Trend Strength | -2.055% (StdDev 4.11%) | Hourly BBV | -1 () | Intraday Trend | 0% | | | |
|
Resistance Level | $8.06 | 5 Day Moving Average | $8.43(-4.98%) | 10 Day Moving Average | $8.19(-2.2%) | 20 Day Moving Average | $8.06(-0.62%) | To recent high | -12.6% | To recent low | 16.4% | Market Cap | $662m | | | | Compugen Ltd. engages in the research, development, and commercialization of therapeutic and diagnostic biomarker product candidates including proteins and monoclonal antibodies. It focuses its research and development on immuno-oncology and autoimmune diseases. The company was founded by Eli Mintz, Simchon Faigler, and Amir Natan on February 10, 1993 and is headquartered in Holon, Israel. |